Jason Terrell
Chief Tech/Sci/R&D Officer chez GENEREX BIOTECHNOLOGY CORPORATION
Profil
Jason Bradley Terrell is currently the Director at Terrell Oil & Gas Production Co., Inc. He also holds the position of Chief Scientific & Medical Officer at Generex Biotechnology Corp.
and Chief Medical Officer at NuGenerex Immuno-Oncology, Inc. Additionally, he is a Member-Development Board at Hardin-Simmons University and Assistant Professor-Oncology at Dell Medical School.
Previously, he served as the President at Volition America, Inc. and Manager at Volition Veterinary Diagnostics Development LLC.
He has also held positions as the Non-Executive Chairman at Kiromic Biopharma, Inc., Director & Medical Director at CDEX, Inc., and Medical Director at Any Test Franchising, Inc. Furthermore, he was the Chief Medical Officer & Head-US Operations at VolitionRX Ltd.
Dr. Terrell completed his undergraduate studies at Hardin-Simmons University and obtained a doctorate degree from The University of Texas Medical School At Houston in 2006.
Postes actifs de Jason Terrell
| Sociétés | Poste | Début |
|---|---|---|
| GENEREX BIOTECHNOLOGY CORPORATION | Chief Tech/Sci/R&D Officer | 01/02/2017 |
| NUGENEREX IMMUNO-ONCOLOGY, INC. | Chief Tech/Sci/R&D Officer | - |
| Terrell Oil & Gas Production Co., Inc. | Director/Board Member | - |
| Dell Medical School | Corporate Officer/Principal | 01/01/2017 |
Volition America, Inc.
 Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | President | 16/11/2021 |
| Hardin-Simmons University | Corporate Officer/Principal | - |
| Volition Veterinary Diagnostics Development LLC | Corporate Officer/Principal | 28/05/2019 |
Anciens postes connus de Jason Terrell
| Sociétés | Poste | Fin |
|---|---|---|
| VOLITIONRX LIMITED | Chief Tech/Sci/R&D Officer | 18/11/2022 |
| KIROMIC BIOPHARMA, INC. | Chairman | 01/09/2019 |
| ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Jason Terrell
| Hardin-Simmons University | Undergraduate Degree |
| The University of Texas Medical School At Houston | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VOLITIONRX LIMITED | Health Technology |
| KIROMIC BIOPHARMA, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Generex Biotechnology Corp.
 Generex Biotechnology Corp. Pharmaceuticals: MajorHealth Technology Generex Biotechnology Corp. is an integrated healthcare holding company with end-to-end solutions for patient centric care from rapid diagnosis through delivery of personalized therapies. It builds new kind of healthcare company, which provides support to physicians in an MSO network, and ongoing relationships with patients to improve the patient experience and access to optimal care. The company was founded by Rose C. Perri on September 4, 1997 and is headquartered in Miramar, FL. | Health Technology |
CDEX, Inc.
 CDEX, Inc. Packaged SoftwareTechnology Services CDEX, Inc. operates as a technology development company. It has interest in processing technology for substance verification, authentication, and identification in the field of healthcare, security and public safety, and brand protection. The firm also offers detection solutions for counterfeit or sub-par products for brand protection. The company was founded on July 6, 2001 and is headquartered in Tucson, AZ. | Technology Services |
NuGenerex Immuno-Oncology, Inc.
 NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |
| Terrell Oil & Gas Production Co., Inc. | |
Any Test Franchising, Inc.
 Any Test Franchising, Inc. Miscellaneous Commercial ServicesCommercial Services Any Test Franchising, Inc. engages in the provision of lab testing services. It offers testosterone lab tests, menopause screening panel, allergy testing, lipid panel, teen drug testing, employer drug and alcohol testing, mixed martial arts fighter panel, paternity testing, and deoxyribonucleic acid testing for immigration. The company was founded by David Perlow in 1992 and is headquartered in Alpharetta, GA. | Commercial Services |
Volition America, Inc.
Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Health Services |
| Volition Veterinary Diagnostics Development LLC |
